These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1911190)

  • 1. Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens.
    Kosmas C; Epenetos AA; Courtenay-Luck NS
    Br J Cancer; 1991 Sep; 64(3):494-500. PubMed ID: 1911190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer.
    Kosmas C; Epenetos AA; Courtenay-Luck NS
    Cancer; 1994 Jun; 73(12):3000-10. PubMed ID: 8199996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours.
    Durrant LG; Doran M; Austin EB; Robins RA
    Int J Cancer; 1995 Mar; 61(1):62-6. PubMed ID: 7705934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
    Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
    Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
    Tan P; Anasetti C; Martin PJ; Hansen JA
    J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of humoral and cellular immunity in patients developing human anti-murine immunoglobulin antibody responses after radioimmunotherapy.
    Kosmas C; Man S; Epenetos AA; Courtenay-Luck NS
    Br J Cancer Suppl; 1990 Jul; 10():85-8. PubMed ID: 2383486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM; Szewczuk MR
    Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells.
    Verhagen AM; Brandon MR; Nash AD
    Immunology; 1993 Jul; 79(3):471-8. PubMed ID: 8406574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a T-cell determinant defined by a monoclonal antibody (TH5.2) which is involved in the interleukin-2-producing and proliferative capabilities of T cells.
    Yoshihara PH; Thieme T; Finke P; Barney C; Tong A; Burger DR
    Cell Immunol; 1987 Aug; 108(1):10-27. PubMed ID: 3111721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
    Gangemi RM; Swack JA; Gaviria DM; Romain PL
    J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
    Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
    J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori.
    Karttunen R
    Clin Exp Immunol; 1991 Mar; 83(3):396-400. PubMed ID: 1900743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R; Archibald J; Gress RE
    J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
    Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes.
    Rowan WC; Hale G; Tite JP; Brett SJ
    Int Immunol; 1995 Jan; 7(1):69-77. PubMed ID: 7718516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo.
    Noujaim AA; Schultes BC; Baum RP; Madiyalakan R
    Cancer Biother Radiopharm; 2001 Jun; 16(3):187-203. PubMed ID: 11471484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.